baber/WOPTO huggingface dataset:
Patent NZ-509676-A (NZ)
Title: Ticket redistribution system
Inventor: GEBB LUCAS
IPC: G06Q10/02
Filed: 1999-06-21
Abstract: The present invention includes a reliable and efficient method for redistributing, purchasing or selling tickets on the secondary market. The system generally includes a method for accepting tickets from individual sellers, posting the tickets on a central database for redistribution, establishing a market price based on demand and/or a service fee (this feature may not be available in certain states due to resale restrictions or at certain arenas due to prior agreements) and redistributing the tickets to new buyers. The system allows sellers to reach a wider market and also gives more individuals an opportunity to conveniently purchase tickets to events at a reasonable price. Individual buyers are not forced to deal directly with brokers, scalpers or other types of sellers, and thus, are substantially protected from fraud. To protect the buyer, the present invention verifies all tickets posted on the database and, to protect the seller, verifies the buyer's credit card and guarantees payment to the seller.
Patent NZ-510007-A (NZ)
Title: Use of pramipexole in the treatment of restless legs syndrome
IPC: A61K31/425
Filed: 1998-01-16
Abstract: Disclosed is a method for treating restless legs syndrome in a non-human patient in need thereof, comprising the administration of an effective amount of the compound 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexole). (62) Divided out of 336804
Patent NZ-514175-A (NZ)
Title: Matting agents for thermally curable systems
Inventor: GROB CARMELINA
IPC: C09D5/00
Filed: 2000-03-07
Abstract: A matting agent for thermally curable systems comprises at least one carboxyl containing polymer as binder and at least one epoxy-group containing compound as crosslinking agent. The matting agent comprises at least (a) a metal salt or a metal complex of an organic compound and (b) a polymerization product of monomers. Overall the ratio of epoxy equivalents of component (b) to metal equivalents of component (a) is 0.2 to 120. The metal is magnesium, calcium, strontium, barium, zinc, aluminum, tin or antimony. The monomers include epoxy-group containing monomers and the epoxy value of the polymerization product is 1 to 8 equivalents of epoxy groups per kilogram.
Patent NZ-517052-A (NZ)
Title: Veneer lathe
Inventor: WATANABE KENZO
IPC: B27L5/02
Filed: 2002-02-05
Abstract: A veneer lathe can be driven under the condition such that a veneer produced by cutting out a log is substantially free from surface scratch and can be used as a sheet of plywood.  A roller bar (3) drives a log while pushing its peripheral surface on the upstream side of the knife fixed to a knife carriage for cutting the rotating log in a log rotating direction.  The roller bar (3) has a large number of grooves defined in the peripheral surface thereof.  The shape of the grooves (5a) in a section crossing the shaft centerline of the roller bar (3) is set so that an angle between a tangent at a corner portion (3e) constituted by a line (3d) of an outer periphery of the roller bar (3) and a line (3b) extending outward from the side of the shaft centerline of the roller bar (3), and the line (3b) extending outward, is 130 to 160 degrees.
Patent NZ-517219-A (NZ)
Title: Nucleic acids and polypeptides used to modulate the biological activity of a C2GnT3 polypeptide and treat proliferative diseases such as cancer and thymus-related disorders
Inventor: SCHWIENTEK TILO
IPC: C12N1/21
Filed: 2000-08-24
Abstract: A gene defining a human UDP-GlcNAc: Galâ1-3GalNAcalpha â1, 6GlcNAc-transferase, termed C2GnT3, with unique enzymatic properties is disclosed. Principally disclosed are isolated DNA molecules and DNA constructs encoding C2GnT3, as well as cloning and expression vectors including such DNA. The enzyme C2GnT3-active derivatives thereof are disclosed, in particular soluble derivatives comprising the catalytically active domain of C2GnT3. Further disclosed are methods of obtaining 1,6-N-acetylglucosaminyl glycosylated saccharides, glycopeptides or glycoproteins by use of an enzymatically active C2GnT3 protein or fusion protein thereof or by using cells stably transfected with a vector including DNA encoding an enzymatically active C2GnT3 protein. Methods are disclosed for the identification of agents with the ability to inhibit or stimulate the biological activity of C2GnT3.
Patent NZ-523222-A (NZ)
Title: Combinatorial libraries enhanced by recombination in yeast and analytical method
Inventor: TRUAN GILLES
IPC: C12Q1/68
Filed: 2001-06-13
Abstract: Described are methods for constructing combinatorial functional expression libraries using a combinatorial library of nucleic acids belonging to the same gene family. The combinatorial library of nucleic acids is introduced into a yeast simultaneously with an expression vector, and obtaining the functional expression library by homologous or homeologous recombination. Also described are methods for producing functional active mosaic proteins using the library and methods for analyzing the combinatorial library.
Patent NZ-524080-A (NZ)
Title: Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof
Inventor: PLATZEK JOHANNES
IPC: C07D295/22
Filed: 2001-07-23
Abstract: Disclosed are Perfluoroalkyl-containing complexes with polar radicals of general formula (I); in which, Rf is a perfluorinated, straight-chain or branched carbon chain with the formula -CnF2nE, in which E represents a terminal fluorine, chlorine, bromine iodine or H atom, and n stands for 4-30; K stands for a metal complex of general formula (II), (III) (IV), (VA) or (VB), (VI) or (VII); G represents a radical that is functionalized in at least three places and that is selected from formulas (a) to (i), whereby alpha means the binding site of G to complex K, beta is the binding site of G to radical R and gamma represents the binding site of G to radical Z; Z stands for formula (VIII). Further disclosed are processes for the production of compounds of the general formula (I), and the use of these compounds for the production of contrast media for use in NMR and X-ray diagnosis, infarction and necrosis imaging, radiodiagnosis and radiotherapy, and other forms of medical imaging.
Patent NZ-525488-A (NZ)
Title: Autogenous rotor
Inventor: VAN DER ZANDEN JOHANNES PETRUS
IPC: B02C13/18
Filed: 2001-10-25
Abstract: The device relates to an autogenous rotor that rotates about an axis of rotation, which rotor is provided with at least one guide member for accelerating material, which guide member is associated with a chamber member where an autogenous bed of material builds up, with the aid of which guide member material is guided into a spiral path in the direction of said chamber member where said accelerated material impinges the said autogenous bed at a predetermined impingement location, after which said material moves from said impingement location along said autogenous bed in the direction of said tip, under the influence of centrifugal force, where said material is propelled outwards from said rotor.
Patent NZ-525733-A (NZ)
Title: Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
Inventor: BANHOLZER ROLF
IPC: A61K31/00
Filed: 2001-09-28
Abstract: A crystalline monohydrate of (1á, 2â, 4â, 5á, 7â)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane-bromide (tiotropium bromide monohydrate). A process for the production of the abovementioned compound is also disclosed and pharmaceutical compounds having an anticholinergic activity, suitable for the treatment of COPD and asthma.
Patent NZ-527765-A (NZ)
Title: Reactive non-isocyanate coating compositions
Inventor: SHALATI MOHAMAD DEEB
IPC: C09D201/06
Filed: 2002-02-27
Abstract: Reactive, non-isocyanate coating compositions prepared by mixing epoxy, tertiary amine-, anhydride-, hydroxy- and, optionally, acid-functional compounds, a system of making the coating composition, and a substrate coated with the composition are disclosed.
Patent NZ-528122-A (NZ)
Title: Universal ski and snowboard binding
Inventor: MILLER MATHEW E
IPC: A63C9/086
Filed: 2002-02-15
Abstract: A universal binding apparatus for detachably securing footwear to an article is disclosed . The apparatus includes a base plate and a foot plate. The base plate attaches to the article while the foot plate attaches to the footwear. The base plate includes a toe latch, a heel latch, and a first release. The toe latch is disposed at a front portion of the base plate while the heal latch is disposed at a rear portion of the base plate such that the first release is also disposed between the toe latch and the heel latch. The first release enables either the toe latch or the heel latch to be disengaged from the foot plate. The foot plate includes a toe support and a heel support. The toe support is disposed at a front portion of the shoe plate similar to the front portion of the base plate and while the heel support is disposed at a rear portion of the shoe plate. The shoe plate removably attaches to the base plate with the toe support engaged with the toe latch and the heel support engaged with the heel latch. The first release operates to disengage either the toe latch or the heel latch or both from the foot plate.
Patent NZ-528432-A (NZ)
Title: packetizing multimedia data and depacketizing multimedia data
Inventor: PARK JEONG-HOON
IPC: H04N21/2383
Filed: 2000-06-12
Abstract: A method of packetizing multimedia data to transmit multimedia data comprises:- (a) Aligning a data unit generated in the application layer within a data unit of the layer below the application layer while data packetizing is performed in the layer between an application layer and a physical layer. (62) Divided Out of 509330
Patent NZ-530052-A (NZ)
Title: A payment system
Inventor: MCPHAIL ANDREW MICHAEL
IPC: G06Q20/04
Filed: 2002-05-08
Abstract: A payment and distribution system that facilitates the payment for goods delivered to a first party, for example, a retailer, from a second party, for example, a wholesaler, by a third party delivery agent. The System includes a remote delivery terminal that is associated with a delivery vehicle of the delivery agent. The terminal is responsive to the first party and/or the delivery agent, for providing a confirmation signal to confirm that the goods have been transported to the first party and to provide a predetermined value for the goods. A provider server is operated by a fourth party provider for receiving the confirmation signal and for maintaining a first account for the first party and a second account for the second party, wherein, in response to the confirmation signal, the first account is debited and the second account is credited.
Patent NZ-533677-A (NZ)
Title: Method of treating halitosis
Inventor: BOLIN TERRY DORCEN
IPC: A61K33/24
Filed: 2002-11-27
Abstract: Disclosed are: a method of treating halitosis in a non-human vertebrate in need of said treat wherein said halitosis is associated with sulfite-reducing bacteria in the gut of said vertebrate, said method comprising administering to the vertebrate a therapeutically effective amount of a bismuth salt or bismuth containing composition; a method of treating halitosis in a non-human vertebrate in need of said treatment, wherein said halitosis is associated with sulfite-reducing bacteria, said method comprising detecting the presence of a sulfite reducing bacterial population in the gut of said vertebrate, and when present, administering a therapeutically effective amount of a bismuth salt or bismuth containing composition to said vertebrate; and the use of an effective amount of a bismuth salt or bismuth containing composition for the manufacture of a medicament for treating halitosis in a vertebrate, wherein said halitosis is associated with sulfite-reducing bacteria in the gut of said vertebrate.
Patent NZ-534258-A (NZ)
Title: Methods and compositions for regrowth of cryopreserved conifer embryos
Inventor: LARSON BONNIE
IPC: A01H4/00
Filed: 2004-07-22
Abstract: Describes a method for regrowth of cryopreserved conifer embryogenic cells, comprising the steps of: contacting cryopreserved conifer embryogenic cells with a liquid transition medium; and culturing the contacted conifer embryogenic cells in, or on, a solid or liquid regrowth medium to produce regrowth of the conifer embryogenic cells wherein the liquid transition medium and the regrowth medium comprise a principal carbohydrate source selected from the group of maltose, glucose, or a combination thereof.
Patent NZ-534605-A (NZ)
Title: Spatial field effect physical therapy device
Inventor: ZHENG JIBING
IPC: A61N5/00
Filed: 2003-01-14
Abstract: A spatial field effect physical therapy device, including a base and (64) equidistant Yijing columns fitted on the base in the form of a square by (8) rows and (8) columns, each Yijing column is at a height of (2) to (18) unit length, in the rectangle consisted of arbitrary (4) Yijing columns, the sums of the heights of the Yijing columns at the ends of each diagonal of the rectangle is equal to each other. This spatial field effect physical therapy device needn't an incoming energy and is able to cure pains in human body effectively.
Patent NZ-535074-A (NZ)
Title: Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
Inventor: LEE SE-JIN
IPC: A61P21/00
Filed: 2001-07-26
Abstract: A method of modulating an effect of myostatin on a cell in vitro, comprising contacting the cell with an agent that affects myostatin signal transduction in the cell, wherein the agent comprises (a) an agent that alters a specific interaction of myostatin with an activin receptor, with the proviso that the agent is not an antibody, (b) a growth and differentiation factor (GDF) prodomain or a functional peptide portion thereof, which specifically interacts with myostatin, (c) a polynucleotide encoding a mutant myostatin receptor, which specifically binds myostatin, wherein the mutant receptor does not activate myostatin signal transduction, (d) a polynucleotide encoding a peptide that affects the level or activity of an intracellular polypeptide in a myostatin signal transduction pathway, or (e) a polynucleotide comprising or encoding an antisense c-ski nucleotide sequence or an antisense Smad nucleotide sequence, and wherein the agent is a polynucleotide, said contacting comprises introducing the polynucleotide into the cell, is disclosed. The use of the described agent that affects myostatin signal transduction in a cell, for the preparation of a medicament for the treatment of a pathological condition selected from a muscle wasting disorder, cachexia, anorexia and metabolic disorder, is also disclosed. (62) Divided out of 523617
Patent NZ-535717-A (NZ)
Title: Method of manufacturing foamed composite
Inventor: VOICE DEAN MAXWELL
IPC: B29C44/12
Filed: 2003-03-26
Abstract: A method of manufacturing a glass fibre reinforced structural composite article, said method comprising the steps of spraying a mechanically blended polyester foam into a mould whilst simultaneously introducing chopped glass fibre. The mechanically blended polyester foam is foamed utilising a gas, and said polyester foam includes a polyester resin that has a viscosity in the range of 12000 - 15000 cP (Brookfield LVT sp. 4/12 rpm). An article manufactured by this method can be made without the necessity of rolling to remove air bubbles, and has a density in the range of 0.6 to 0.8 g/cubic cm.
Patent NZ-538592-A (NZ)
Title: Form-retaining pad for preparing a beverage suitable for consumption
Inventor: STEENHOF VINCENT JAN
IPC: B65D85/804
Filed: 2003-08-25
Abstract: The invention relates to a reform-retaining pad (1), an assembly and a method for preparing a beverage suitable for consumption. For this purpose, the pad is provided with a covering (2), in which a water-soluble substance (4), such as milk power/creamer and sugar, is included. The covering comprises a top sheet (6) and a bottom sheet (8). The pad is further provided with a form-providing stiffening body (10), placed between the top sheet and the bottom sheet, with the top sheet and the bottom sheet extending at least partly substantially parallel to each other and the surface. The stiffening body has a top side adjacent to the top sheet and a bottom side adjacent to the bottom sheet, and, by providing a compartmenting wall configuration therein, has a grid structure (14) transmissive to liquid, in which structure at least a part of the soluble substance is accommodated and each compartment (16) formed by the wall configuration is surrounded by that wall configuration, the top sheet and the bottom sheet.
Patent NZ-539603-A (NZ)
Title: Use of fulvestrant in the treatment of resistant breast cancer
Inventor: THURLIMANN BEAT
IPC: A61K31/4196
Filed: 2001-04-02
Abstract: Use of fulvestrant in the preparation of a medicament for the treatment of a patient with breast cancer who previously has been treated with an aromatase inhibitor and tamoxifen, and has failed with such previous treatment.
Patent NZ-542161-A (NZ)
Title: A roof element
Inventor: KELLY GRAEME OWEN
Filed: 2005-08-31
Abstract: A roof element for covering the container portion of a truck, the element including: a cover adapted to be placed in an open and a closed configuration; and a reel adapted to locate the cover in its closed configuration, the reel being adjacent the surface of a container and extending along the length of the container surface, the roof element forming a cover over the container when the cover is in an open configuration. The roof element also includes at least one displacement means configured to move the reel between a default position and a loading position, the default position being above the loading position.
Patent NZ-544298-A (NZ)
Title: Cannabinoid receptor modulators including benzofuran derivatives
Inventor: OHKAWA SHIGENORI
IPC: A61P27/06
Filed: 2004-06-25
Abstract: Disclosed are benzofuran compounds where X is oxygen and the remaining substituents are as defined in the specification. The compounds are cannabinoid receptor modulators.
Patent NZ-545599-A (NZ)
Title: A device that is pushed into the gap between panels in constructing a wall or similar, that then snaps into place to cover the gap
Inventor: WILLIAMS KEVIN
IPC: E04F13/08
Filed: 2004-09-24
Abstract: A device (10) for bridging a gap between panels is disclosed. The device comprises a flange (11) that covers the gap between two sheets (52), an extension member (12) that extents from the flange (11) that ends in at least one retaining member (13) that snaps into position on the far faces of the panels (52,) causing the devise (10) to be retained against the opposite faces. When inserted into the gap the retaining member(s) (13) are deflected from an initial configuration to a second configuration. After the device (10) is completely inserted the retaining member(s) (13) return to the initial configuration. The flange (11) is also urged into a second configuration from an initial configuration by being held against the outside faces of the panels.
Patent NZ-548121-A (NZ)
Title: Sleeved stop for a drill bit with coarse and fine adjustment and biased centering member
Inventor: GREENBERG ALEX M
IPC: A61B17/16
Filed: 2004-12-29
Abstract: A stop for use with an electric drill bit, the stop having a combination of sleeves with differing thread pitch to provide for coarse and fine adjustment of the stop. The stop also has a centering member for use in a countersink (not shown) including a spring so that the centering member is biased to a fully extended position. Shoulder 106 limits depth of drilling when the spring is fully compressed.
Patent NZ-550315-A (NZ)
Title: Genes and polypeptides from Y. entomophaga MH96 associated with insecticidal activity
Inventor: HURST MARK ROBIN HOLMES
IPC: C12P1/04
Filed: 2006-10-04
Abstract: Disclosed are nucleic acid and polypeptide molecules associated with the insecticidal toxin produced by  ersina entomophaga MH96. The nucleic acid and polypeptide molecules can be used in the manufacture of a composition suitable for use as a biopesticide.
Patent NZ-550968-A (NZ)
Title: Microfluidic device
Inventor: ROBILLOT CEDRIC EMILE FRANCOIS
Filed: 2005-09-02
Abstract: A closed loop microfluidic device that has at least one microchannel (74) formed in a body and a pump (72) in fluid connection with the microchannel. The pump is actuated by an external motive force to push and pull fluid through the microchannel. A number of chambers (73, 76) are formed in fluid connection with the microchannel to store reagents. The reagents are moved through the microchannel by the pump. A number of active zones (70, 71) are also formed in the microchannel. Various reactions and diagnostics are performed at the active zone. A sample is introduced to the microchannel through a sealable input port (77). The microchannel forms a closed loop with all necessary reagents and diagnostics contained within the closed loop microfluidic device. The sample is processed and analysed completely within the closed loop microchannel.
Patent NZ-554633-A (NZ)
Title: Delivery devices and their uses
Inventor: GREEN KEVIN GEORGE
Filed: 2004-09-09
Abstract: An intraruminal device capable of releasing at least two active ingredients is disclosed. The device includes an elongate body impervious to rumen fluids, where the body defines a barrel having a first outlet, a column of matrices in the barrel having one or more active ingredients, a compression arrangement within the body, and a release arrangement. The column of matrices within the barrel is biased so as to present each matrix to the first outlet. A release arrangement for an active ingredient is provided at or adjacent the end of the body distal to the first outlet.
Patent NZ-555482-A (NZ)
Title: Compositions comprising a 5HT2C receptor modulator and 2-methylamphetamine and methods of use
Inventor: BEHAN DOMINIC P
IPC: A61K31/135
Filed: 2005-12-21
Abstract: Disclosed is a composition comprising phentermine or a pharmaceutically acceptable salt thereof and a selective 5HT-2C receptor agonist that is selective for a 5HT-2C receptor compared to another receptor that decreases food intake of a mammal, wherein the selective 5HT-2C receptor agonist is selected from the group consisting of: (R)-1-(5-chloro-2-fluoro-phenyl)-2-methylpiperazine; a benzazepine compound of structural Formula (I); a pharmaceutically acceptable salt, solvate, hydrate, enantiomer or diastereomer of a compound of Formula 1); and a racemate comprising said enantiomer or diastereomer. The composition is useful in the treatment of obesity.
Patent NZ-561609-A (NZ)
Title: 3-((trifluoromethyl)sulfonyl)benzenesulfonamide and 3-((chloro(difluoro)methyl)sulfonyl)benzenesulfonamide apoptosis promoters
Inventor: BRUNCKO MILAN
IPC: A61K31/496
Filed: 2006-05-12
Abstract: Disclosed are compounds of formula (II), wherein the substituents are as defined in the specification. The compounds inhibit the activity of anti-apoptotic Bcl-2 family protein members and are useful in the treatment of bladder cancer, brain cancer, breast cancer, bone marrow cancer, cervical cancer, chronic lymphocytic leukemia, colorectal cancer, esophageal cancer, hepatocellular cancer, lymphoblastic leukemia, follicular lymphoma, lymphoid malignancies of T-cell or B-cell origin, melanoma, myelogenous leukemia, myeloma, oral cancer, ovarian cancer, non-small cell lung cancer, prostate cancer, small cell lung cancer or spleen cancer.
Patent NZ-562970-A (NZ)
Title: Improved spade type-bit
Inventor: DURFEE LAVERNE R
Filed: 2007-10-30
Abstract: A spade type drill bit is disclosed. The bit comprises a shank (2) having a cutting member (6) located at one of the ends, the cutting member includes a pair of helically shaped opposing blades (16) which extend around a longitudinal axis of the shank in an arc, and an axially extending threaded pilot screw (30) conical in shape and having an angle (Mu) of between 15 and 35 degrees.